Document Detail

Helicobacter pylori eradication: A randomised comparative trial of 7-day versus 14-day triple therapy.
MedLine Citation:
PMID:  22668909     Owner:  NLM     Status:  In-Data-Review    
Background. Helicobacter pylori is associated with several upper gastrointestinal conditions including chronic gastritis, peptic ulcer disease, and gastric malignancy. Proton pump inhibitor-based triple therapies are considered the standard regimens for H. pylori eradication, but the optimal duration of therapy is controversial. To prevent infection and complications, local studies should be undertaken to evaluate H. pylori eradication rates in a country. Objectives. We compared 7-day and 14-day regimens to determine the optimum duration of triple therapy for H. pylori eradication. Methods. We undertook a prospective randomised comparative trial of 7-day and 14-day triple therapy regimen for H. pylori eradication at the Aga Khan University Hospital, Nairobi; 120 patients with dyspepsia and H. pylori infection were randomised to receive esomeprazole, amoxicillin and clarithromycin for either 7 days (EAC 7) or 14 days (EAC 14). Compliance and side-effects were assessed 2 weeks after the start of therapy and H. pylori eradication was assessed by stool antigen tests 4 weeks after treatment. Results. Both the intention-to-treat (ITT; N=120) and per protocol (PP; N=97) analyses showed no significant differences between the eradication rates of EAC 7 (ITT 76.7%; PP 92%) and EAC 14 (ITT 73.3%; PP 93.6%) (ITT p=0.67; PP p=0.76). Poor compliance was reported in one patient in the EAC 14 group. The incidence of adverse events was comparable in the two groups. Conclusion. One-week and 2-week triple treatments for H. pylori eradication are similar in terms of efficacy, safety and patient compliance.
Ahmed Sokwala; Mahesh V Shah; Smita Devani; Gerald Yonga
Related Documents :
16151029 - Determinants of caregiving burden and quality of life in caregivers of stroke patients.
17627239 - Quality of life after randomization to laparoscopic versus open living donor nephrectom...
19415379 - The feasibility and efficacy of a multidisciplinary intervention with aftercare meeting...
20094949 - Surgical repair of pelvic-floor prolapse: lessons learned from longitudinal follow-up o...
20564089 - Health-related quality of life in patients with spinal metastases treated with or witho...
8905859 - Assessing the expected outcomes of orthopedic surgical care for children.
24875469 - Arthroscopic hip revision surgery for residual femoroacetabular impingement (fai): surg...
21958889 - Left atrial contractile function following a successful modified maze procedure at surg...
21575939 - A double-blind randomized controlled trial of vaginal misoprostol for cervical priming ...
Publication Detail:
Type:  Journal Article     Date:  2012-05-08
Journal Detail:
Title:  South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde     Volume:  102     ISSN:  0256-9574     ISO Abbreviation:  S. Afr. Med. J.     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-06-06     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0404520     Medline TA:  S Afr Med J     Country:  South Africa    
Other Details:
Languages:  eng     Pagination:  368-71     Citation Subset:  IM    
Department of Medicine, Aga Khan University Hospital, Nairobi.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Fresh-frozen plasma use in a South African tertiary hospital.
Next Document:  Suicidal ideation and attempt among South African medical students.